Tracking the OCT Revolution

Journal/Article Reprint from OCT IQ Center

Because anti-VEGF drugs, and therapies such as lasers and steroids, produce limited durations of effect and better outcomes on early-stage disease, there exists a need for heightened monitoring of existing retinal patients and quicker diagnosis of new ones. OCT excels at both and this article outlines how.

Already a member? Click here to sign in

Step 1: Not registered? Please complete this form to view content

Step 2: Create Your Medical Product Guide Account

Step 3: Create Your Professional Information

By clicking the button above you agree to our Terms of Use. We take your privacy seriously. For more information please read our Privacy Policy. By registering with the Enterprise Guide you will automatically receive our weekly Product Update and Technology Insider eNewsletters.

Please provide the following information and a representative of OCT IQ Center will contact you to assist with any questions you might have.